Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition

Kaaks, Rudolf; Rinaldi, Sabina; J. Key, Timothy; Berrino, Franco; H M Peeters, P; Biessy, Carine; Dossus, Laure; Lukanova, A.; Bingham, Sheila; Khaw, K-T; E. Allen, Naomi; Bas Bueno‐de‐Mesquita, H.; H. van Gils, Carla; E. Grobbee, Diederick; Boeing, Heiner; H. Lahmann, Petra; Nagel, Gabriele; Chang‐Claude, Jenny; Clavel‐Chapelon, Françoise; Fournier, A.; C. M. Thiébaut, Anne; A. González, Carlos; Quirós, J.R.; Tormo, MJ; Ardanáz, Eva; Amiano, Pilar; Krogh, Vittorio; Palli, Domenico; Panico, Salvatore; ­Tumino, ­Rosario; Vineis, Paolo; Trichopoulou, Antonia; Kalapothaki, V.; Trichopoulos, D.; Ferrari, Pietro; Norat, T.; Saracci, Rodolfo; Ríboli, Elio

doi:10.1677/erc.1.01038

Public

Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition

Published in Endocrine Related Cancer • Dec 1, 2005

Authors:

Rudolf Kaaks

Sabina Rinaldi

Timothy J. Key

Abstract

Considerable experimental and epidemiological evidence suggests that elevated endogenous sex steroids - notably androgens and oestrogens - promote breast tumour development. In spite of this evidence, postmenopausal androgen replacement therapy with dehydroepiandrosterone (DHEA) or testosterone has ...

Subject

Sex hormone-binding globulin

Internal medicine

Androstenedione

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!